Patient Education Alliance

The Patient Education Alliance is the Foundation for Women’s Cancer’s most comprehensive educational sponsorship. It offers the opportunity to support the core educational needs of our patient community and expanded impact, visibility, and collaboration for our partners throughout the year.

We are grateful to our 2024/25 partners for their unwavering commitment to education and outreach.

Eisai Co., Ltd. is a Japanese pharmaceutical company.
GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company.
Karyopharm is a pharmaceutical company.
Labcorp is a pharmaceutical company.
At Merck, we're following the science to tackle some of the world's greatest health threats.
Pfizer is a pharmaceutical company.

For more information about this program, please contact Gail O’Hara, MBA, Director of Corporate and Foundation Relations.

Partnerships

The Patient Education Alliance is the Foundation for Women’s Cancer’s new, comprehensive educational sponsorship opportunity. This annually-renewed program offers opportunity to support the core educational needs of our patient community and expanded impact, visibility and collaboration for our partners throughout the year.

We are grateful to our inaugural partners for their unwavering commitment to education and outreach.

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company.
Eisai Co., Ltd. is a Japanese pharmaceutical company.
Genmab A/S is a Danish biotechnology company.
GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company.
At Merck, we're following the science to tackle some of the world's greatest health threats.
Seagen is a global biotechnology company dedicated to revolutionizing cancer care.

For more information about this program, please contact Teri Jordan, Chief Industry Relations and Development Officer.

Partnerships

The Patient Education Alliance is the Foundation for Women’s Cancer’s new, comprehensive educational sponsorship opportunity. This annually-renewed program offers opportunity to support the core educational needs of our patient community and expanded impact, visibility and collaboration for our partners throughout the year.

We are grateful to our inaugural partners for their unwavering commitment to education and outreach.

For more information about this program, please contact Teri Jordan, Chief Industry Relations and Development Officer.